SCHEMBL25797908

SCHEMBL25797908

Cc1cc(N[C@@H]2CCCN(C)C2)nnc1-c1ccc(C2CCC2)cc1

nearest known ligand 0.70

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ NLRP3 Q96P20 11/20 0.70
▸ IL1B P01584 13/20 0.59
▸ EGLN2 Q96KS0 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25798309 0.97 NLRP3 (0.74) NLRP3IL1BEGLN2
SCHEMBL25797819 0.89 NLRP3 (0.65) NLRP3IL1B
SCHEMBL25797812 0.87 NLRP3 (0.78) NLRP3IL1B
SCHEMBL25798457 0.87 IL1B (0.74) NLRP3IL1B
SCHEMBL25798335 0.87 NLRP3 (0.68) NLRP3IL1B
SCHEMBL25798059 0.86 NLRP3 (0.65) NLRP3IL1B
SCHEMBL25797798 0.85 NLRP3 (0.61) NLRP3IL1B
SCHEMBL25797965 0.85 IL1B (0.61) NLRP3IL1B
SCHEMBL25298003 0.84 IL1B (0.75) NLRP3IL1B
SCHEMBL25298002 0.84 IL1B (0.75) NLRP3IL1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023129987-A1 PYRIDAZINE DERIVATIVES AS MODULATORS OF NLRP3 INFLAMMASOME AND RELATED METHODS Neumora Therapeutics, Inc. (US) 2023-07-06 — — WO disclosed
Send feedback